As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.
33 Analysts have issued a Exact Sciences Corporation forecast:
33 Analysts have issued a Exact Sciences Corporation forecast:
Jun '25 |
+/-
%
|
||
Revenue | 2,940 2,940 |
13%
13%
|
|
Gross Profit | 2,005 2,005 |
5%
5%
|
|
EBITDA | 66 66 |
175%
175%
|
EBIT (Operating Income) EBIT | -151 -151 |
17%
17%
|
Net Profit | -1,005 -1,005 |
474%
474%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.
Head office | United States |
CEO | Kevin Conroy |
Employees | 6,950 |
Founded | 1995 |
Website | www.exactsciences.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.